The company fully deploys the work in the second half of the year
Release time:
2020-08-14
Company Fully Deploys Work in the Second Half of the Year
News 7# July 19 , the Group Company Held an Analysis Meeting on Production and Operation Work in the First Half of the Year to Summarize and Review the Work in the First Half of the Year and Make Arrangements for the Work in the Second Half of the Year. At the
meeting, the heads of professional companies and directly affiliated enterprises reported the operation and management work in the first half of the year, and focused on analyzing the problems existing in the work and putting forward corresponding countermeasures. Lan Xiaolong, head of finance of the group company, Xiang Chongping, deputy general manager, and Chen Tianci, assistant to the general manager, respectively summarized the financial work, information construction, and "three reductions and three improvements" in the first half of the year. Yu Jianhong, general manager of
Group Company, made a comprehensive summary of the work of the Group Company in the first half of the year. In the first half of this year, the semi-annual operating profit of the group company created an all-time high; investment and cooperation projects have also made good progress; product development and technological transformation have achieved initial results; information construction has been steadily advanced; safety, environmental protection and internal control management have been further developed. However, the strategic decision-making and development ability, innovation ability and innovation consciousness of the management of each enterprise need to be improved, which restricts the further development of the company.
After analyzing the current macroeconomic situation, especially the industry situation faced by the two major businesses, Yu Jianhong made the following arrangements for the company's main work in the second half of the year: further clarify strategic thinking, change concepts, and unify Understanding, find the strategic positioning and direction; strengthen innovation, strive to innovate from technology, management, marketing, business model, management system, etc., and establish corresponding incentive mechanisms; improve the evaluation and incentive system, accelerate the training of talents; use informatization and intelligent construction as the starting point to further optimize the management structure and improve management standards; strive to break through the "bottleneck" of marketing; collect and analyze information through information technology to improve information collection and analysis capabilities, Provide information support for improving decision-making level, management level, and market expansion capabilities; strengthen the quality training of all employees, so that job optimization can truly improve work efficiency.
meeting also clearly put forward the management objectives of each enterprise in the second half of the year. (Reporter Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page